Eli Lilly Drugstore LLC (Lilly) and the Department of Health – Abu Dhabi (DoH), regulator of the healthcare sector in Abu Dhabi, have signed a Memorandum of Understanding (MoU) at the BIO International Convention 2026, in San Diego, USA to address obesity and Alzheimer’s disease, two of the most pressing health challenges in the region. Through this landmark collaboration, Lilly and DoH will explore establishing an AI enabled obesity healthcare model and a world-class Alzheimer's Disease Centre of Excellence in Abu Dhabi. The collaboration combines Lilly’s deep therapeutic expertise and ...